4//SEC Filing
Trigilio Jeffrey 4
Accession 0000950170-23-031858
CIK 0001789972other
Filed
Jul 4, 8:00 PM ET
Accepted
Jul 5, 9:27 PM ET
Size
5.2 KB
Accession
0000950170-23-031858
Insider Transaction Report
Form 4
Trigilio Jeffrey
Chief Financial Officer
Transactions
- Award
Common Stock
2023-06-30$9.08/sh+2,340$21,247→ 88,163 total
Footnotes (2)
- [F1]The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Issuer's 2021 Employee Stock Purchase Plan (the "ESPP"), for the purchase period of January 1, 2023 through June 30, 2023. This transaction is also exempt under Rule 16b-3(c).
- [F2]In accordance with the ESPP, the shares were purchased based on 85% of the closing price of the Issuer's common stock on January 1, 2023.
Documents
Issuer
Cullinan Oncology, Inc.
CIK 0001789972
Entity typeother
Related Parties
1- filerCIK 0001838671
Filing Metadata
- Form type
- 4
- Filed
- Jul 4, 8:00 PM ET
- Accepted
- Jul 5, 9:27 PM ET
- Size
- 5.2 KB